Literature DB >> 9877462

Prevalence of hypertension in patients with type II diabetes in referral versus primary care clinics.

W V Moore1, D Fredrickson, A Brenner, B Childs, O Tatpati, J M Hoffman, R Guthrie.   

Abstract

We compared the prevalence of hypertension in patients with non-insulin-dependent diabetes mellitus (NIDDM) in referral and primary care practices using definitions of The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC-V), while controlling for other risk factors such as hypertension, obesity, smoking, and age. Patients (n = 1443) were enrolled consecutively from a large referral practice at the Jackson Diabetes Center and four primary care clinics in the vicinity. Blood pressures were measured at three clinic visits after a 5-min rest in a sitting position using a standard clinical sphygmomanometer. Charts were reviewed to determine diabetes duration, insulin usage, height, weight, smoking history, use of antihypertensive and oral hypoglycemic medications, socioeconomic status, and race. Patients were classified as hypertensive based on JNC-V definitions or if they were on antihypertensive medication. Hypertension was termed uncontrolled if blood pressure was JNC-V Stage 2 or higher while on antihypertensive medication. Seventy-eight percent of referral clinic and 55% of primary care clinic patients had either JNC-V State 1 or higher hypertension or were on antihypertensive medication. Actual blood pressures indicated that more patients had JNC-V Stage 1 (mild) or higher hypertension in referral compared to primary care clinics (62% versus 48% p = 0.01) but fewer had JNC-V Stage 2 or higher (moderate-severe) hypertension (12% versus 19% p = 0.002). Patients seen in the referral clinic were significantly more likely to have greater age, greater duration of diabetes, higher insulin dosage, longer smoking history, antihypertensive medication, and live outside the metropolitan area. By logistic regression, the odds of hypertension were significantly increased with age (OR 1.51/decade), BMI greater than 27 (OR 2.17), diabetes duration (OR 1.04/year), and insulin dosage (OR 1.74/U/kg). Current smoking and attending a referral clinic were not significantly related. The odds of moderate-severe hypertension were significantly increased with age (OR 1.23/ decade), decreased by attending a referral clinic (OR 0.45), and not significantly related to other confounders in the model. The prevalence of hypertension among patients with NIDDM was higher in referral than primary care clinics. The higher prevalence in the referral practice can be accounted for by the greater severity of associated risk factors in the referral practice patients; however, most patients will be diagnosed and treated for hypertension prior to referral. More patients in the referral practice were on hypertensive medication, which lowered the stage or severity of hypertension but still not to the normal range. The results suggest that the primary detection of hypertension in patients with type II diabetes resides with the primary care physician. Management of hypertension will require both a delineation and acceptance of responsibilities between the primary care physician and diabetes specialists.

Entities:  

Mesh:

Year:  1998        PMID: 9877462     DOI: 10.1016/s1056-8727(98)00009-9

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  8 in total

1.  PREVALENCE OF COEXISTING DIABETES MELLITUS AND HYPERTENSION AMONG DENTAL PATIENTS IN A TERTIARY CARE HOSPITAL.

Authors:  O I Opeodu; B F Adeyemi
Journal:  J West Afr Coll Surg       Date:  2015 Jul-Sep

Review 2.  Treatment and blood pressure control in 47,964 people with diabetes and hypertension: a systematic review of observational studies.

Authors:  Donna L McLean; Scot H Simpson; Finlay A McAlister; Ross T Tsuyuki
Journal:  Can J Cardiol       Date:  2006-08       Impact factor: 5.223

3.  Prevalence of hypertension in Type-2 diabetes mellitus.

Authors:  Mohammad Wali Naseri; Habib Ahmad Esmat; Mohammad Daud Bahee
Journal:  Ann Med Surg (Lond)       Date:  2022-05-14

4.  Dietary Sodium Intake in Type 2 Diabetes.

Authors:  Laura Ferreira Provenzano; Sue Stark; Ann Steenkiste; Beth Piraino; Mary Ann Sevick
Journal:  Clin Diabetes       Date:  2014-07

5.  Duloxetine in the management of diabetic peripheral neuropathic pain.

Authors:  Michelle J Ormseth; Beth A Scholz; Chad S Boomershine
Journal:  Patient Prefer Adherence       Date:  2011-07-19       Impact factor: 2.711

6.  The Ontario printed educational message (OPEM) trial to narrow the evidence-practice gap with respect to prescribing practices of general and family physicians: a cluster randomized controlled trial, targeting the care of individuals with diabetes and hypertension in Ontario, Canada.

Authors:  Merrick Zwarenstein; Janet E Hux; Diane Kelsall; Michael Paterson; Jeremy Grimshaw; Dave Davis; Andreas Laupacis; Michael Evans; Peter C Austin; Pamela M Slaughter; Susan K Shiller; Ruth Croxford; Karen Tu
Journal:  Implement Sci       Date:  2007-11-26       Impact factor: 7.327

7.  Prevalence of Diabetes Mellitus and Its Risk Factors among Permanently Settled Tribal Individuals in Tribal and Urban Areas in Northern State of Sub-Himalayan Region of India.

Authors:  Dhiraj Kapoor; Ashok Kumar Bhardwaj; Dinesh Kumar; Sunil Kumar Raina
Journal:  Int J Chronic Dis       Date:  2014-05-06

8.  Dietary Sodium Intake in People with Diabetes in Korea: The Korean National Health and Nutrition Examination Survey for 2008 to 2010.

Authors:  Myung Shin Kang; Chong Hwa Kim; Su Jin Jeong; Tae Sun Park
Journal:  Diabetes Metab J       Date:  2016-06-23       Impact factor: 5.376

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.